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Introduction
Bilirubin, which is produced during the catabolism of hemoglobin, can exist in several isomeric forms [1] . 4Z,15Z-bilirubin-IXα (4Z,15Z-BR) is the main isomer in the body and can cause kernicterus in newborns.
The neurotoxicity of 4Z,15Z-BR is most probably related to its extremely low solubility in water at neutral pH [2] . The neurotoxicity of the pigment is diminished, and its solubility in aqueous media is increased on binding to human serum albumin (HSA), to which it binds with a high-affinity constant in the order of 10 7 -10 8 M -1 . Hydrogen bonds, aromatic π-π and hydrophobic interactions are important for binding [3, 4] .
On the other hand, the conversion of 4Z,15Z-BR to 4Z,15E-BR by photosentization results in the formation of a geometric isomer that has a lower binding affinity to HSA but a higher water solubility, which permits it to be excreted more easily than the precursor 4Z,15Z-BR [5] .
HSA is the most abundant protein in plasma and is responsible for most of the oncotic pressure. It is a simple protein without prosthetic groups and does not contain any glycan chains and, hence, is not a glycoprotein. It is a heart-shaped protein comprised of three homologous domains, each of which is further divided into two subdomains A and B [6] . HSA binds a variety of different endogenous substances such as fatty acids, bilirubin, various uremic toxins and thyroxines. Two discrete drug binding sites designated as
Sudlow Site I and Site II have also been found on subdomains IIA and IIIA, respectively [6] .
Affinity binding experiments of 4Z,15Z-BR with albumin fragments point to a fragment comprised of amino acid residues from about 180 to 250, which roughly correspond to subdomain IIA [7] . Petersen et al. [8] studied the binding of 4Z,15Z-BR to eight different HSA mutants in which amino acids assumed to be important for binding had been mutated. Surprisingly, none of the single-amino acid substitutions had any significant effect on the binding of 4Z,15Z-BR. This result was taken to indicate the existence of a dynamic, unusually flexible high-affinity binding site for 4Z,15Z-BR in subdomain IIA. In addition, the bisignate CD spectra of 4Z,15Z-BR becomes inverted when 4Z,15Z-BR binds to various mammalian albumins with more than an 80% homology with HSA [9] .
In thermodynamic studies of interactions of 4Z,15Z-BR and HSA, ΔH° and ΔS° were found to be -13.5
kcal / mol and -0.0085 kcal / mol / K, respectively [3] . The large negative free energy for the interaction, which is mainly the result of a large enthalpy change, suggests the importance of electrostatic rather than hydrophobic interactions. Earlier studies proposed that the bound BR interacts with histidine, arginine, tyrosine [10] and lysine residues [11] [12] [13] [14] , especially buried lysine residues [15] , but not with Lys240 [16] .
Hence, salt linkages between the carboxyl groups of BR and ε-NH 2 groups of lysine residues of HSA appear to be necessary for the binding of BR [10, 17] . Therefore, it is highly possible that the multiple pattern binding mode is due to the formation of a flexible 4Z,15Z-BR-HSA complex, and that no single crucial binding mode exists, but multiple interactions are ongoing between 4Z,15Z-BR and HSA [11] [12] [13] [14] [15] [16] [17] . In order to conduct a binding site topology analysis, it becomes necessary to simultaneously introduce multiple mutations into domain II. However, one of the inherent limitations of point mutation techniques is that it requires the selection of a reasonably small number of residues as targets. To overcome this limitation, phage display technology, which can be used to efficiently perform multiple mutations, represents an alternative and potentially useful approach. Phage display is a powerful technology for identifying polypeptides with novel properties, and altering the properties of existing ones [18] [19] [20] [21] [22] . Phage display has been used in epitope mapping and studies of protein-protein interactions. This technique involves the insertion of a foreign DNA fragment in the structural gene of a bacteriophage, which leads to the expression of a peptide or protein at the surface of the viral particle. The rapid isolation of specific ligands by phage display is advantageous in many applications, including the selection of inhibitors for active and allosteric sites of enzymes, receptor agonists and antagonists, and specific ligands isolated from phage libraries can also be used in therapeutic target validation, drug design and vaccine development. The use of this technology to identify amino acid residues that are involved in ligand binding is not uncommon. The purpose of this study was to identify the functional amino acid residues in HSA that play a role in high-affinity 4Z,15Z-BR binding by constructing a phage display library using the M13 phage. We selected domain II that contains the binding site of 4Z,15Z-BR as the display protein. Since electrostatic interactions have been shown to be an important factor in the binding of 4Z,15Z-BR to HSA, we screened the role of two positively charged amino acid residues, namely lysine and arginine, which could potentially participate in electrostatic interactions with the carboxylate groups of 4Z,15Z-BR.
Results

Construction of a Phage Library displaying HSA-domain II
We initially displayed the wild type HSA-domain II (residues 187-385, 22 kDa) on the M13KO7 phage, as described in the Experimental Procedures section. The expression of the HSA-domain II on the phage was confirmed by an enzyme-linked immunosorbent assay (ELISA). Both the HSA-domain II displaying phage and the M13KO7 helper phage were equally reactive against the anti-M13KO7 antibody, while only the HSA-domain II displaying phage showed specific activity for the anti-HSA polyclonal antibody (Fig. 1 ).
These results confirm that the HSA-domain II is displayed on the M13 phage. In the second phase of this study, we constructed a phage library displaying mutated versions of recombinant HSA-domain II. Because 4Z,15Z-BR contains two carboxyl groups, previous researchers have proposed that basic residues, lysine and/or arginine, are key residues that interact with the carboxyl groups of 4Z,15Z-BR via salt bridge formation [11] [12] [13] [14] [15] [16] . To test this hypothesis and to identify the positions of such key residues, the eight lysines and four arginines located in subdomain IIA were randomly substituted with basic lysine or arginine, neutral glycine or acidic glutamic acid residues. To produce these substitutions, the lysine and arginine codons were replaced with RRA (where R represents A / G) in the cDNA library. Because RRA encodes only four codons (AAA: Lys, AGA: Arg, GAA: Glu, GGA: Gly), the bias of this library can be assumed to be insignificant.
As shown in Figure S3 , the sequences of unselected 24 phages, displayed little or no bias. The library contained approximately 1.7 × 10 7 phage clones, a size that covers all potential clones that can be expressed.
Biopanning and Evaluation of 4Z,15Z-BR Binding Capacity of Selected Clones
In order to identify the recombinant HSA-domain II displaying phages with high 4Z,15Z-BR binding affinities, the phage library was subjected to three rounds of panning against 4Z,15Z-BR immobilized on an EAH Sepharose 4E gel. The recovery rate of each round was calculated and are listed in These deletions and mutations are the result of the fact that the phagemid vector contains a single-stranded DNA, which is relatively unstable, and/or that the HSA sequence has a stretch of five A bases which is a spontaneous mutational "hot spot" [23] . The remaining 8 clones retained the sequence of domain II and were numbered serially ( Fig. 2A) . As seen from the figure 2A, (Fig. 3A) . Consistent with the domain II studies, both point mutations, K195A and K199A, resulted in significantly weaker 4Z,15Z-BR binding to full body HSA mutants (Fig. 3B ).
The interaction of 4Z,15Z-BR with full body HSA and mutants was also investigated by fluorescence spectroscopy. The binding constant (Ka) for wild type HSA was determined to be 5.03 ± 0.53 × 10 7 M -1 (Table 2 ). This value is reasonably consistent with the value for the high-affinity binding constant of 1.56 × 10 7 M -1 reported by Petersen et al. [8] , who used a peroxidase protection assay, and to that (1. (Table 2) . Thus, the two point mutations both resulted in a 5-fold reduction in binding affinity for 4Z,15Z-BR.
Binding conformation of 4Z,15Z-BR to wild type and mutant proteins of domain II and HSA examined
with CD spectroscopy Figure 4B shows that the binding of 4Z,15Z-BR to wild type domain II results in an induced 4Z,15Z-BR -CD spectra typical for the P enantiomer of 4Z,15Z-BR (Fig. 4B) . Introduction of the K195A mutation had little effect on the spectra. In contrast, in the case of the K199A substitution, the 4Z,15Z-BR -CD spectra was altered and resembled the form typical for the M enantiomer. As illustrated in figure 4C , essentially the same observations were made for full body HSA, i.e., the substitution of Lys195 with an alanine has a small effect on the CD spectra, whereas the same type of substitution for Lys199 has a dramatic, inverting effect on the 4Z,15Z-BR -CD spectra. The relatively small amplitudes observed for the wild type and K195A domain II preparations can be attributed to the weaker binding of the P form of 4Z,15Z-BR to these domain preparations and / or that the bend angle between the two dipyrrole chromophores of 4Z,15Z-BR had been modified.
A similar mutation-induced trend was found for the domain II preparations as for the full body HSAs both with respect to changes in binding ( Fig. 3A and B) and with respect to changes in the CD spectra for bound 4Z,15Z-BR ( Fig. 4B and C). These findings indicate that the high-affinity 4Z,15Z-BR site is contained within domain II. However, because the changes are quantitatively different, the detailed structure of the 4Z,15Z-BR -domain II complex is most probably different from those formed with full body HSA.
4Z,15Z-BR binding to recombinant domain I
The binding of 4Z,15Z-BR to wild type domain I (residues 1-186) is significantly lower than binding to wild type domain II. Furthermore, 4Z,15Z-BR, when bound to domain I, adopts an unusual M-conformation which is quite different from the typical P-conformation when binding to domain II and full body HSA ( Fig.   5A and B).
4Z,15Z-BR binding to albumins of different species
HSA shows the highest binding affinity for 4Z,15Z-BR, follow by albumins from bovine and sheep.
Dog albumin shows the weakest binding affinity for 4Z,15Z-BR (Fig. 6A ). As shown in figure 6B and S4, the preferred binding conformation for dog and rat albumins is the P-form, whilst the M-form is the preferred binding conformation for bovine and sheep albumins.
Photoconversion of 4Z,15Z-BR bound to HSA, albumins of different species or HSA mutants
4Z,15Z-BR bound to wild type HSA and the K195A mutant showed a more rapid photoconversion rate than that for the K199A mutant (Fig. 7A ). On the other hand, HSA and dog albumin showed a faster photoconversion rate than bovine and sheep albumins (Fig. 7B ).
Discussion
Identification of the key 4Z,15Z-BR binding amino acid residues in domain II of HSA with phage display
The use of a phage display permitted the presentation of (poly) peptides as fusion bodies to capsid proteins on the surface of bacterial viruses or phage particles. The novel display formats, in vitro selection via innovative library designs and screening strategies, enabled the rapid identification and optimization of proteins based on their structural or functional properties. Recombinant techniques have been developed to increase the diversity of the library. Phage display technology has been used to develop polypeptides with novel properties and small antibodies such as scFv. There are some examples of "non-antibody" proteins that are macromolecular proteins displayed on a phage such as protective antigen protein domain 4 (24kDa) [19] , insulin-like growth factor I (14.5 kDa) [20] , human growth hormone (22 kDa) [21] and glutathione S-transferase (25 kDa) [22] .
HSA is a single stranded polypeptide that folds to form a heart shape protein containing 3 homologous domains. A HSA fragment comprised mainly of domain II has been shown to house the primary binding site for 4Z,15Z-BR [24] . The aim of this study was to identify amino acid residues in HSA-domain II that are of importance for the high-affinity binding of the 4Z,15Z-BR. In a previous study, Dockal et al. successfully expressed and characterized each individual HSA domain [25] . Therefore, taking advantage of the fact that each of the three HSA domains can be independently produced using recombinant techniques without significant disruption of the secondary and tertiary structures, it was possible to display a large number of domain II mutants on the phage and screen for candidate residues for 4Z,15Z-BR binding.
Libraries with various biases can be created for specific purposes when the sequence of the peptide that binds to the target is known, and its affinity can be selectively increased by screening libraries created with limited mutagenesis of the peptide. In this study, the lysine and arginine codons located in subdomain IIA
were replaced with RRA (where R represents A / G) in the cDNA library. Because RRA encodes only four codons (AAA: Lys, AGA: Arg, GAA: Glu, GGA: Gly), the bias of this library is considered to be insignificant. Figure S3 shows the sequences of the unselected library phages that display little or no bias.
This phage library was composed of approximately 1.7 × 10 7 clones. A reasonably sized, diverse library ensures that every possible clone is represented in the library. In fact, the input phage number at round 1 was 3.0 × 10 13 (TU) which is sufficient to cover the diversity requirement of a phage library (Table 1) . Using the phage library, the screening results indicated that Lys195 and Lys199 in the native HSA-subdomain IIA appeared to play an important role in the binding of BR, which contains two free carboxyl groups. Based on the phage display results, the role of Lys195 and Lys199 in binding 4Z,15Z-BR was further examined by site-directed mutagenesis.
Binding affinity of 4Z,15Z-BR to HSA
The findings reported so far indicate that mutations of Lys195 and Lys199 in subdomain IIA of HSA to alanine residues caused an increase in the concentration of unbound 4Z,15Z-BR, indicating that both lysine residues are involved in the binding of 4Z,15Z-BR ( [25] . We also reported previously that the recombinant albumin domain II protein binds warfarin and DNSA only negligibly [26] . This indicates that the integrity of the binding pocket in domain II is affected by interdomain interactions between domains I and III.
Goncharova and Urbanová [27] proposed that ligands with a carboxylate group may interact with the positively charged Lys199, Arg222 and Arg257 residues in subdomain IIA. On the other hand, in an x-ray crystallographic study, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), a dicarboxylic acid-containing renal toxin, has been shown to have five hydrogen-bond or salt-bridge interactions with Tyr150, Lys199, Arg222, His242 and Arg257 [28] . In a previous study, we found that CMPF competitively retained an arginine at 199 but a glycine was located at position 195. In addition, the concentration of free 4Z,15Z-BR for K199A was higher than that for K195A and wild type HSA in this study. In an x-ray crystallographic study of drug-HSA complexes, Ghuman reported that the polar groups of Lys199 and Lys195 were clustered with other polar amino acid residues at the entrance of the binding pocket of subdomain IIA, whilst only the aliphatic portion of Lys199, which contributes to the delineation of the subchamber, protrudes from the front of the pocket [28] . This shows that Lys199 plays more than one role in the binding of 4Z,15Z-BR.
Petersen et al. [8] studied the binding of 4Z,15Z-BR to HSA preparations with several single-amino acid substitutions, including K195M and K199M, and found that none of the mutants had a significantly altered affinity for 4Z,15Z-BR. This is in contrast to the present study, in which we found that the binding of 4Z,15Z-BR to K195A and K199A was diminished ( charge, whereby a potential Lys195 → Lys199 proton-transfer process via water bridges has been proposed [15] . The model illustrates the complexity of the key residue, Lys199, ionization state and the nearby Lys195 has on the structure and dynamics of the IIA binding site.
Enantioselective binding of 4Z,15Z-BR to HSA
The fully protonated unconjugated 4Z,15Z-BR diacid and the dianion adopt a folded biplanar ridge-tile structure analogous to a half-opened book which is stabilized through intramolecular hydrogen bonding of each of the two carboxylate groups to the oxygen and nitrogen of the opposing dipyrrole (Fig. 4A) . This explains the considerable lipophilicity of the pigment compared to its biogenetic precursor biliverdin and is a dominant factor in its metabolism, antioxidant behavior, and toxicity [1] . The right-handed configuration is denoted as P (plus) and the left handed one as M (minus), referred to as the P-helicity folded conformer (P-form) and the M-helicity folded conformer (M-form) [29] . In solution at 37°C, the two mirror-image forms interconvert rapidly, forming a 50:50 mixture of P and M conformers. Nevertheless, when a chiral complexation agent such as serum albumin is added, the equilibrium shifts toward either the M or P enantiomer. In such cases one observes typically intense bisignate CD cotton effects. The conformational structure of the bound pigment, hence the shape and nature of the binding site on HSA can be inferred from the CD data [13] .
As evidenced from the 4Z,15Z-BR-induced CD spectra, mutations of Lys195 and Lys199 to alanine effectively changed the binding microenvironment of the 4Z,15Z-BR binding site to different extents depending on the location of the mutation and, thus, the preferred binding conformation of 4Z,15Z-BR. The preferred binding conformation of BR by wild type HSA is the P-form, as shown in figure 4C . The mutation on K195A had only a minor decreasing effect on the intensities of the spectra, and the P-form of 4Z,15Z-BR remains the preferred binding conformation at the binding site (Fig. 4C) . However, when Lys199 is substituted with an alanine, the spectra for 4Z,15Z-BR changed dramatically, indicating that the M-form was the preferred binding conformation in the absence of a lysine aliphatic side chain at location 199. A similar binding chirality preference could also be observed for the wild type, K195A and K199A recombinant domain II proteins (Fig. 4B ).
Interestingly, albumins of different species also showed such preferred binding conformation of 4Z,15Z-BR depending of the species. Pistolozzi et al. reported that induced CD spectra of 4Z,15Z-BR bound to rat albumin was observed as P-form [9] , which is in agreement with our finding. As shown in figure 6B and S4, the P-form is the preferred binding conformation for human, dog and rat albumins whilst the M-form is the preferred binding conformation for bovine and sheep albumins ( Fig. 6B and S4) . A trend was found when the amino acid sequences of the albumins were compared where the preferred P-form of albumins of humans and dogs contain lysines at positions 195 and 199, the rat albumin contains an arginine at 195 [9] , while bovine and sheep albumins, with the M-form preferred, contain arginines at position 195 and 199 (Table 3) . Hence, Lys199 is a key amino residue responsible for P-form preferred binding conformation of 4Z,15Z-BR by albumin. Since the mutation of lysine to methionine at position 199 had no effect on changing the P-form binding preference of HSA in the point mutation study reported by Petersen [8] , this provides a demonstration of the role of an aliphatic side chain at position 199 in determining the helicity of 4Z,15Z-BR in the binding preference of albumin.
Albumin has been found to facilitate a conformational change in 4Z,15Z-BR into a more water soluble form during phototherapy [5] . The physiological significance of the preference for a 4Z,15Z-BR binding conformation by albumin was evident in a further investigation of the effect of photoirradiation on 4Z,15Z-BR and albumin mixtures. In general, the P-form preferred binding albumins facilitated a faster transformation of the low solubility 4Z,15Z-BR into more water soluble forms of 4Z,15Z-BR, as shown in figure 7B for the human and dog. A similar observation was obtained when both wild type and K195A mutant HSA that preferentially bind the P-form exhibited a faster transformation of 4Z,15Z-BR. In contrast, the mutation of Lys199 to alanine effectively changed the binding preference to the M-form, and thus a slower photoconversion rate of the low solubility 4Z,15Z-BR (Fig. 7A ). This observation also points to the importance of an aliphatic side chain at position 199 for the efficient photoconversion of 4Z,15Z-BR to occur.
Zunszain et al. [30] recently published a crystallographic analysis of HSA complexed with 4Z,15E-BR (Fig. 8A) . The analysis revealed that this isomeric form of the pigment binds with a high affinity to a pocket in subdomain IB, and that the carboxylate groups enter into salt-bridges with arginine residues at position 117 and 186 but not to lysine residues. Our results showed that 4Z,15Z-BR binds to domain I with a lower affinity than to domain II (Fig. 5A ) and in an atypical M-helicity conformation instead of the usual P-form (Fig. 5B) . Thus it is possible that subdomain IB is a binding site for 4Z,15E-BR, but may not be the primary high affinity binding site for 4Z,15Z-BR. However, further investigations will be needed to investigate the possible photoconversion of 4Z,15Z-BR to 4Z,15E-BR that leads to a shift in the binding site from subdomain IIA to subdomain IB.
Potential clinical usefulness of domain II in hyperbilirubinemia
The present work laid the groundwork for development of new therapeutic agents for treating jaundiced newborns. The major treatment for 4Z,15Z-BR-induced encephalopathy in newborns and especially in premature infants is phototherapy, which converts 4Z,15Z-BR, which primarily binds to its high affinity HSA binding site into more soluble nontoxic structural isomers that are more easily eliminated from the circulatory system. The rate of formation of isomers and the isomeric composition of the reaction products have been shown to be highly dependent on the conformation and electronic environment of 4Z,15Z-BR bound to HSA [8, 31] . The results of this study show that the P-form of 4Z,15Z-BR is more readily converted into photoisomers with higher water solubility than the M-form (Fig. 7) . In a previous study, we reported that there was about a 50-fold difference in total clearance between HSA and individual recombinant domains including domain II [26] . Similar observations have been reported by Sheffield et al.
using recombinant domains of rabbit serum albumin [32] . This indicates that HSA-domain II with preserved
Lys199 could be useful in treating jaundiced newborns without being dependent on a premature liver, because it preferentially binds the P-form of 4Z,15Z-BR with a comparable high affinity, and more importantly it would be cleared from the body via the kidney at a rate 50 times faster than whole albumin.
Concluding remarks
Using a phage display system, we have successfully displayed domain II of HSA on M13 phages and identified two key lysine residues, K195 and K199, that are involved in the binding of 4Z,15Z-BR. Further investigations indicated that K199 plays additional roles, compared to K195, in that it is a determinant of the helicity of the P-form of 4Z,15Z-BR, which affects the binding preference of albumin, thus leading to a more rapid photoconversion of 4Z,15Z-BR into a more water soluble molecule for subsequent renal elimination.
Materials and Methods
Construction of a Phage Library Displaying Recombinant HSA-domain II
HSA-domain II cDNA containing sites for restriction enzymes Sfi I and Not I, located at the N and C terminus, respectively, was constructed. The plasmid pCANTAB 5E also contained Sfi I and Not I sites, and both HSA-domain II cDNA and pCANTAB 5E were digested with Sfi I / Not I and ligated using T4 DNA ligase. Plasmid pCANTAB 5E encoding HSA-domain II, in which the C terminus of HSA-domain II was fused to the N terminus of the M13 phage gene 3 signal sequence, was confirmed by DNA sequence analysis.
Oligos 1-6 were designed to have the sequence "RRA" (or TYY in the complementary strand), where R and Y represent G / A and C / T, respectively, at the HSA-subdomain IIA codons for Lys190, Lys195, Arg197, Lys199, Lys205, Arg209, Lys212, Arg218, Arg222, Lys225, Lys233 and Lys240. The sequence RRA can randomly encode for Lys, Arg, Gly and Glu, without bias. Mutagenic double-strand DNAs were synthesized from these oligonucleotides using Klenow fragment (TaKaRa, Kyoto, Japan). Prepared double-strand DNAs with oligo 1-2, 3-4 and 5-6 are denoted as fragment 1, 2, 3, respectively (Fig. S1 ).
To identify key residues of importance for the binding of BR to HSA, we prepared a HSA display phage library. Because it is most likely that the present isomer of BR binds to domain II, we proceeded to display that domain. As seen in figure S1 , the synthesized double-strand DNA fragments were elongated and amplified by PCR using PfuUltra High-Fidelity DNA polymerase (Stratagene, La Jolla, CA, USA). Finally, mutagenized HSA-subdomain IIA cDNA was ligated into pCANTAB 5E.
Biopanning
200 μl of BR coupling gel was blocked with 1 ml of 0.5% gelatin overnight at room temperature. 1 ml of the phage library was added to the gel, which was then allowed to bind for 2 h at 37°C. After binding, the gel 
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